WASHINGTON — Scientists are testing blood from more than 1,000 women for a protein that might signal breast cancer, hoping to create for women the kind of blood test men have for prostate disease.

NEWTON, Mass.--(BUSINESS WIRE)--May 10, 2004--Matritech (AMEX: MZT) a leading developer of protein-based diagnostic products for the early detection of cancer, today announced the commencement of ...

Matritech Corp. could be the new, new thing in life sciences. Matritech Corp. could be the new, new thing in life sciences. I conclude this after noting the numerous calls and e-mails that have come ...

Bruker Daltonics Inc. said today that it has formed a partnership with Matritech Inc. for an automated cancer-screening test. The companies are developing a mass spectrometer system that will allow ...

All rights to NMP 179 revert to Matritch immediately. Matritech and Sysmex mutually agreed to terminate their agreement related to use of the former’s nuclear matrix protein (NMP) associated with ...

WALTHAM, Mass. and NEWTON, Mass., Aug. 28 -- Inverness Medical Innovations and Matritech today announced that they have entered into an asset purchase agreement pursuant to which Inverness will ...

NEWTON, Mass.--(BUSINESS WIRE)--MZT Holdings, Inc., formerly known as Matritech, Inc. (Amex:MZT), announced today that its stockholders have approved: • the sale of substantially all of the assets of ...

IMA and MZT announce that they have entered into an asset purchase agreement pursuant to which Inverness will acquire substantially all of the assets of Matritech for aggregate consideration of $36 ...

Stock agreement will add point-of-care bladder cancer diagnostic to portfolio. Inverness Medical Innovations is buying Matritech for $36 million in stock. Additionally, Matritech will receive up to $2 ...

WALTHAM, Mass. and NEWTON, Mass., Aug. 28 Inverness Medical Innovations, Inc. (Amex: IMA) and Matritech, Inc.(Amex: MZT) today announced that they have entered into an asset purchaseagreement pursuant ...